                               SEQUENCE LISTING

<110> VOGELSTEIN, BERT
      KINZLER, KENNETH W.
      WANG, QING
      PAPADOPOULOS, NICKOLAS
      ZHANG, MING
 
<120> METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER

<130> 44807-0302WO1

<140> PCT/US2018/062007
<141> 2018-11-20

<150> 62/588,654
<151> 2017-11-20

<160> 23    

<170> PatentIn version 3.5

<210> 1
<211> 9
<212> PRT
<213> Unknown

<220>
<221> source
<223> /note="Description of Unknown: 
      PPIA peptide fragment"

<400> 1
Val Ser Phe Glu Leu Phe Ala Asp Lys 
1               5                   


<210> 2
<211> 9
<212> PRT
<213> Unknown

<220>
<221> source
<223> /note="Description of Unknown: 
      PPIA peptide fragment"

<400> 2
Phe Glu Asp Glu Asn Phe Ile Leu Lys 
1               5                   


<210> 3
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 3
Ile Gln Leu Val Glu Glu Glu Leu Asp Arg 
1               5                   10  


<210> 4
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 4
Val Ile Leu His Leu Lys 
1               5       


<210> 5
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 5
Ile Ile Leu Leu Phe Asp Ala His Lys 
1               5                   


<210> 6
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 6
Thr Leu Ala Glu Ser Ala Leu Gln Leu Leu Tyr Thr Ala Lys 
1               5                   10                  


<210> 7
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 7
Leu Leu Gly His Leu Val Lys 
1               5           


<210> 8
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 8
Gly Leu Val Gly Glu Ile Ile Lys 
1               5               


<210> 9
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 9
Asp Glu Ile Glu Ser Val Lys 
1               5           


<210> 10
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 10
Val Gly Ser Ala Lys Pro Gly Leu Gln Lys 
1               5                   10  


<210> 11
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 11
Glu Thr Ile Val Leu Lys 
1               5       


<210> 12
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 12
Ser Ile Val Asn Tyr Lys Pro Lys 
1               5               


<210> 13
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 13
Asp Leu Gln Phe Val Glu Val Thr Asp Val Lys 
1               5                   10      


<210> 14
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 14
Thr Leu Leu Gly Asp Gly Pro Val Val Thr Asp Pro Lys 
1               5                   10              


<210> 15
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 15
His Phe Thr Ile Leu Asp Ala Pro Gly His Lys 
1               5                   10      


<210> 16
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 16
Leu Val Asp Lys Phe Leu Glu Asp Val Lys 
1               5                   10  


<210> 17
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 17
Lys Ile Pro Val Val Phe Arg 
1               5           


<210> 18
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 18
Phe Pro Val Ile Gln His Phe Lys 
1               5               


<210> 19
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 19
Phe Phe Leu Ser His Pro Ala Tyr Arg 
1               5                   


<210> 20
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 20
Leu Phe Ala Gly Leu Val His Val Lys 
1               5                   


<210> 21
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 21
Val Leu Asp Phe Glu His Phe Leu Pro Met Leu Gln Thr Val Ala Lys 
1               5                   10                  15      


<210> 22
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 22
Leu Leu Gly Asn Val Leu Val Cys Val Leu Ala His His Phe Gly Lys 
1               5                   10                  15      


<210> 23
<211> 11
<212> PRT
<213> Unknown

<220>
<221> source
<223> /note="Description of Unknown: 
      K-Ras wild-type (WT) peptide"

<400> 23
Leu Val Val Val Gly Ala Gly Gly Val Gly Lys 
1               5                   10      


